Mail & Guardian
Mail & Guardian
public healthlatest news & developments
South Africa’s first generic semaglutide injection launched in August — and Sahpra is considering 13 more applications. Photo: Haberdoedas Photography/Pexels 

The first generic weight loss drug hit SA in August — with many expected to follow. Will it be enough to kill the black market?

As patents expire, generic versions of blockbuster weight-loss and diabetes drugs like Ozempic arrive in South Africa. But will price drops be enough to end the dangerous black…

Sardine deaths along Cape coast: PHV detected as Koeberg Unit 1 cuts power

Pilchard herpesvirus is emerging as the prime suspect in the mass mortality of sardines along the Cape coast, an incident that prompted beach clean-ups and forced Eskom's Koeberg…

Foot-and-Mouth Disease: South Africa's quiet business crisis

Foot-and-Mouth Disease is not just a farming issue; it's a profound South African crisis affecting food security, farmers, and the vital informal trading sector, with…

Video

SA and Zambia’s HIV shot dilemma: Demand versus supply

South Africa and Zambia are grappling with a significant challenge in rolling out lenacapavir, a new six-monthly HIV prevention injection. Despite high demand and promising early…

Sardine deaths: high levels of pilchard herpesvirus found in South African fish

High levels of pilchard herpesvirus have been found in sardines involved in South Africa’s extensive mortality event, with the virus detected in all 15 fish in an initial…

In 2024, global coal consumption reached a record high, with commercial banks investing more than $130 billion across Asia, the US and Europe.. (Paul Botes)

#CancelCoal: SCA to hear government appeal over 1 500MW new coal plan

Youth and environmental organisations are back in court to defend their 2024 victory against 1,500MW of new coal-fired power, as Electricity and Energy Minister Kgosientsho…

 (Reuters/Mike Segar)

No girl should face this alone: Why China and the UN are standing together for Lesotho's girls

In the remote highlands of Mokhotlong, Lesotho, adolescent girls and young women face a 'Triple Threat' of high HIV burden, pervasive gender-based violence, and early pregnancy.…

Donor funding is shrinking just as science has delivered powerful new medication that could dramatically cut new HIV infections. Photo: Felipe Varanda/IAS

Aids is no longer exceptional. What happens now?

The International Aids Conference in Rio de Janeiro highlighted a stark reality: the era of Aids exceptionalism is ending amid unprecedented funding cuts. As science delivers…

The unfinished fight for South Africa's young women

Seventy years after the historic Women's March, South Africa reflects on progress while confronting the ongoing challenges faced by young women today, from healthcare access and…

Health advocacy: Nomcebo Dlamini hopes the next generation of women will redefine what leadership looks like. Photo: Supplied

The woman asking South Africa to confront what it has normalised

Nomcebo Dlamini, campaign director of Saapa SA, is leading the charge to challenge South Africa's deeply ingrained drinking culture. She highlights the devastating impact of…

Malaria cases could increase drastically during the Covid-19 pandemic.

Climate change redrawing Africa's malaria map, raising risk in South Africa

A landmark study published in Nature reveals that climate change is reshaping Africa's malaria map, increasing the disease's risk in South Africa's north-eastern provinces and…

#Aids2026: Bhekisisa analysed SA’s first LEN roll-out data. Here's what it found

South Africa accounts for over half of all lenacapavir (LEN) users in Africa, with health department data revealing 31,297 of the continent's roughly 60,000 users are in the…

#Aids2026: Daily pill. Monthly pill. Six-monthly jab. Why choice matters

For the first time, Merck has granted generic manufacturers, including three African companies, permission to produce an investigational monthly HIV prevention pill, alimatravir,…

What HIV got right — but obesity still hasn’t

As the 26th International Aids Conference convenes, this article draws parallels between the HIV response and the emerging obesity crisis in South Africa. It highlights how…

Trust: The legal dispute involving Novo Nordisk and iDexis has intensified these competing narratives.

As it rages, the semaglutide debate exposes public trust deficit in healthcare

The contentious debate around semaglutide in South African healthcare extends beyond its use for obesity and type 2 diabetes, exposing deep-seated issues of access,…

Under pressure: The crisis at Tshilidzini Hospital should not be viewed solely as a provincial healthcare failure, it should also prompt a broader conversation about the governance environment in which public healthcare operates. Photo: X

Hospitals don't create governance failures... they inherit them

Every election, South Africans are promised better healthcare. Yet by the time many patients reach a public hospital, the system has often already begun to fail them—not only…

What The Polygamist gets wrong about HIV — and what would save lives in real life

The Netflix drama "The Polygamist" depicts Jonasi Gomora's death from an AIDS-related illness, but the article argues that HIV isn't the real villain. Instead, it's the denial,…

When sewage floods your home, it floods your mind too

In Nairobi's Mukuru kwa Reuben, residents face a grim reality: homes repeatedly flooded by sewage due to dysfunctional drainage. This article explores the profound psychological…

Costly legal weight-loss drugs are fuelling a black market in unregistered versions, including retatrutide — an experimental medicine still in trials. (Anna-Maria van Niekerk)
Video

Health Beat #39 | Inside SA's illegal weight-loss drug trade

South Africa faces a surge in illegal weight-loss drugs, as expensive GLP-1 medicines drive a black market for cheaper, untested versions. This trend raises serious health…

The recall of iDexus has become the subject of legal proceedings, with
the pharmaceutical company denying it posed a health risk.

Regulators tighten noose on recalled GLP-1 medicines

South Africa's health regulators have warned doctors, pharmacists, and other healthcare professionals that they face disciplinary action for continuing to prescribe or dispense…